Cutler Group’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,500
| Closed | -$2K | – | 1544 |
|
|
2023
Q1 | $2K | Buy |
+1,500
| New | +$2K | ﹤0.01% | 1243 |
|
|
2022
Q1 | – | Sell |
-14,600
| Closed | -$73K | – | 2133 |
|
|
2021
Q4 | $73K | Buy |
14,600
+13,800
| +1,725% | +$69K | ﹤0.01% | 1058 |
|
|
2021
Q3 | $9K | Hold |
800
| – | – | ﹤0.01% | 1725 |
|
|
2021
Q2 | $16K | Hold |
800
| – | – | ﹤0.01% | 1594 |
|
|
2021
Q1 | $22K | Sell |
800
-100
| -11% | -$2.75K | ﹤0.01% | 1441 |
|
|
2020
Q4 | $23K | Hold |
900
| – | – | ﹤0.01% | 1235 |
|
|
2020
Q3 | $33K | Buy |
900
+100
| +13% | +$3.67K | ﹤0.01% | 1010 |
|
|
2020
Q2 | $41K | Buy |
800
+200
| +33% | +$10.3K | ﹤0.01% | 902 |
|
|
2020
Q1 | $18K | Sell |
600
-3,300
| -85% | -$99K | ﹤0.01% | 1010 |
|
|
2019
Q4 | $232K | Buy |
3,900
+1,900
| +95% | +$113K | 0.01% | 476 |
|
|
2019
Q3 | $73K | Buy |
2,000
+600
| +43% | +$21.9K | 0.01% | 692 |
|
|
2019
Q2 | $65K | Sell |
1,400
-1,000
| -42% | -$46.4K | 0.01% | 825 |
|
|
2019
Q1 | $96K | Sell |
2,400
-1,100
| -31% | -$44K | 0.01% | 643 |
|
|
2018
Q4 | $161K | Buy |
3,500
+600
| +21% | +$27.6K | 0.02% | 458 |
|
|
2018
Q3 | $128K | Buy |
+2,900
| New | +$128K | 0.01% | 674 |
|
|
2018
Q2 | – | Sell |
-3,700
| Closed | -$267K | – | 1822 |
|
|
2018
Q1 | $267K | Buy |
3,700
+3,600
| +3,600% | +$260K | 0.02% | 454 |
|
|
2017
Q4 | $6K | Sell |
100
-1,666
| -94% | -$100K | ﹤0.01% | 1748 |
|
|
2017
Q3 | $88K | Sell |
1,766
-9,983
| -85% | -$497K | ﹤0.01% | 1049 |
|
|
2017
Q2 | $543K | Buy |
11,749
+4,504
| +62% | +$208K | 0.02% | 464 |
|
|
2017
Q1 | $255K | Sell |
7,245
-15,121
| -68% | -$532K | 0.01% | 723 |
|
|
2016
Q4 | $280K | Buy |
22,366
+12,511
| +127% | +$157K | 0.01% | 710 |
|
|
2016
Q3 | $136K | Sell |
9,855
-200
| -2% | -$2.76K | 0.01% | 955 |
|
|
2016
Q2 | $99K | Buy |
10,055
+2,809
| +39% | +$27.7K | 0.01% | 1021 |
|
|
2016
Q1 | $122K | Buy |
7,246
+3,668
| +103% | +$61.8K | 0.01% | 834 |
|
|
2015
Q4 | $79K | Buy |
+3,578
| New | +$79K | ﹤0.01% | 1160 |
|